SGMT
#3015
Sagimet Biosciences Inc. - Series A Common Stock
7.5 5 USD
+0.06%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+5.59%
Monthly Change
+15.09%
6 month change
+18.15%
Year Change
-19.68%
Previous Close
7.1 5
Open
7.2 9
Low
7.2 9
High
7.5 9
Volume
335
Financials
- Market Capitalization 466.23 M
- Employee 16
- Founded 2006
- CEO N/A
- Website www.sagimet.com
- Headquarter Delaware, United States
- FIGI BBG0020584Y9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.75
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3010 |  VALN Valneva SE - American Depositary Shares | 5.22 USD | -0.76% | -2.61% | -4.57% | -20.06% | 452.94 M USD | ||
| 3014 |  EVMN Evommune, Inc. Common Stock | 12.32 USD | +1.73% | -9.21% | -38.46% | -28.87% | 443.75 M USD | ||
| 3037 |  CCCC C4 Therapeutics, Inc. - Common Stock | 3.89 USD | -0.77% | -10.37% | -2.26% | +63.45% | 430.11 M USD | ||
| 3048 |  ASMB Assembly Biosciences, Inc. - Common Stock | 27.03 USD | +0.26% | -9.26% | +14.20% | -8.14% | 429.58 M USD |
Frequently asked questions about Sagimet Biosciences Inc. - Series A Common Stock
What is the Sagimet Biosciences Inc. - Series A Common Stock stock price today?
The current price of Sagimet Biosciences Inc. - Series A Common Stock (SGMT) is 7.55. Over the past 24 hours, the stock has changed by +5.59%. Follow the SGMT chart for real-time price dynamics.
What is the stock ticker of Sagimet Biosciences Inc. - Series A Common Stock?
Sagimet Biosciences Inc. - Series A Common Stock trades under the ticker SGMT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Sagimet Biosciences Inc. - Series A Common Stock stock going up?
SGMT has changed by -3.21% over the last week, +15.09% over the last month, and -19.68% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Sagimet Biosciences Inc. - Series A Common Stock net income for the last quarter?
Sagimet Biosciences Inc. - Series A Common Stock reported net income of -10.65 M for the last quarter. The previous quarter showed -9.57 M, which means net income changed by -11.31%.
How many employees does Sagimet Biosciences Inc. - Series A Common Stock have?
As of the latest available data, Sagimet Biosciences Inc. - Series A Common Stock has 16 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Sagimet Biosciences Inc. - Series A Common Stock stock?
You can buy Sagimet Biosciences Inc. - Series A Common Stock (SGMT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Sagimet Biosciences Inc. - Series A Common Stock stock?
Investing in Sagimet Biosciences Inc. - Series A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SGMT chart and related analysis on metatrader.com as part of your research.